Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.9K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

943
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
943
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

414
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
414
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.2K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-hematopoietic erythropoietin splice variant is produced in the diseased human brain and confers neuroprotection.

Frontiers in cellular neuroscience·2026
Same author

Loss of Endothelial YAP/TAZ Reduces the Size of Chronic Stroke Lesions and Alters the Endothelial Environment.

Journal of the American Heart Association·2025
Same author

Sputum host cytokine signatures for diagnosis of TB in children and adults.

Frontiers in immunology·2025
Same author

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE.

Biomedicines·2025
Same author

Unveiling tissue-specific transcriptional adaptations in iPSC-derived fibroblasts via co-culture systems.

Stem cell research & therapy·2025
Same author

Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same journal

Immunity gaps for several vaccine preventable diseases in Norway.

Vaccine·2026
Same journal

Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.

Vaccine·2026
Same journal

Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.

Vaccine·2026
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.6K

High-throughput data analysis and data integration for vaccine trials.

January Weiner1, Stefan H E Kaufmann1, Jeroen Maertzdorf1

  • 1Department of Immunology, Max Planck Institute for Infection Biology, Charitéplatz 1, D-10117, Berlin, Germany.

Vaccine
|May 16, 2015
PubMed
Summary
This summary is machine-generated.

Biomarker studies using systems biology aid vaccine development by analyzing high-throughput data. This review covers methods to integrate and analyze diverse molecular data for predicting vaccine immunogenicity and trial outcomes.

Keywords:
Data integrationSystems biologySystems vaccinology

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

11.4K

Related Experiment Videos

Last Updated: Apr 12, 2026

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.6K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

11.4K

Area of Science:

  • Vaccinology
  • Systems Biology
  • Bioinformatics

Background:

  • Biomarker studies are crucial for rational vaccine development, aiding in predicting, optimizing, and evaluating vaccine immunogenicity.
  • Systems biology approaches generate extensive high-throughput (HT) data, including simple biomarkers and complex biosignatures.
  • Analyzing and integrating large-scale HT data from vaccine trials presents significant computational challenges.

Purpose of the Study:

  • To provide an overview of methods for evaluating and integrating large-scale molecular data from vaccine trials.
  • To describe statistical and bioinformatic approaches relevant to systems biology in vaccinology.
  • To highlight techniques for analyzing diverse HT data types like transcriptomic, proteomic, and metabolic profiles.

Main Methods:

  • Review of statistical and bioinformatic tools for systems biology applications in vaccine research.
  • Description of data dimension reduction techniques for managing large datasets.
  • Explanation of functional analysis and methods for integrating heterogeneous HT data.

Main Results:

  • The review details various methods for processing and analyzing complex molecular data generated in vaccine studies.
  • It covers techniques applicable to transcriptomic, proteomic, and metabolic profiling.
  • Examples of these methods applied to vaccine research and development are provided.

Conclusions:

  • Effective analysis and integration of HT data are essential for advancing vaccine development through systems biology.
  • The described methods offer a framework for leveraging molecular data to improve vaccine design and evaluation.
  • Application of these techniques can lead to better prediction of vaccine efficacy and identification of surrogate endpoints.